MO01.33 CRESTONE – Clinical Study of REsponse to Seribantumab in Tumors with NEuregulin-1 (NRG1) Fusions – A Phase 2 Study of the anti-HER3 mAb for Advanced or Metastatic Solid Tumors (NCT04383210)

D. Spigel, S.N. Waqar,M.E. Burkard,J.J. Lin,Y.K. Chae,M.A. Socinski,S. Gadgeel,K.L. Reckamp, S.M. Leland, D. Plessinger, L. Kunkel, J.R. Bauman, G. Otterson, B. Halmos,S.-H. Ignatius Ou,T. Patil, Y.Y. Elamin,E.S. Kim

Journal of Thoracic Oncology(2021)

引用 1|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要